Knuff & Co LLC Increases Stock Position in Danaher Co. (NYSE:DHR)

Knuff & Co LLC increased its position in shares of Danaher Co. (NYSE:DHR) by 0.8% during the 3rd quarter, Holdings Channel reports. The firm owned 8,258 shares of the conglomerate’s stock after purchasing an additional 68 shares during the quarter. Knuff & Co LLC’s holdings in Danaher were worth $2,296,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in DHR. nVerses Capital LLC purchased a new position in shares of Danaher in the 2nd quarter worth approximately $25,000. CarsonAllaria Wealth Management Ltd. purchased a new position in Danaher in the second quarter worth $25,000. MidAtlantic Capital Management Inc. bought a new position in Danaher in the 3rd quarter valued at $40,000. MFA Wealth Advisors LLC bought a new position in Danaher in the 2nd quarter valued at $51,000. Finally, Financial Connections Group Inc. purchased a new stake in shares of Danaher during the 2nd quarter valued at $51,000. 79.05% of the stock is owned by institutional investors.

Insider Activity at Danaher

In related news, SVP Georgeann Couchara sold 952 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares of the company’s stock, valued at $1,130,374.44. This represents a 18.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by insiders.

Danaher Stock Performance

Danaher stock opened at $229.50 on Tuesday. The firm’s 50 day simple moving average is $261.33 and its 200 day simple moving average is $260.45. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1-year low of $207.63 and a 1-year high of $281.70. The firm has a market capitalization of $165.76 billion, a PE ratio of 43.80, a price-to-earnings-growth ratio of 4.24 and a beta of 0.85.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same quarter last year, the business posted $2.02 earnings per share. The firm’s revenue was up 3.1% compared to the same quarter last year. As a group, analysts expect that Danaher Co. will post 7.51 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.47%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.

Analysts Set New Price Targets

DHR has been the subject of several research reports. Royal Bank of Canada reduced their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research report on Thursday, October 31st. Bank of America lifted their price target on shares of Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a report on Wednesday, July 24th. Barclays reduced their price objective on Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Finally, Wells Fargo & Company began coverage on Danaher in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 target price for the company. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.